Lotus Pharmaceuticals Receives SFDA Approval to Initiate Phase I Clinical … – PR Newswire (press release)

Lotus Pharmaceuticals Receives SFDA Approval to Initiate Phase I Clinical
PR Newswire (press release)
According to IMS Health, a pharmaceutical market research firm, the anti-asthma and chronic obstructive pulmonary disease market in China reached

and more »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.